Crohn’s & Colitis Foundation’s IBD Ventures Awards Investment to Support Development of Medibiofarma’s Novel First-In-Class PPARg Partial Agonist Oral Therapy (MBF-118) for Treatment of Crohn’s Disease Pamplona, Spain / March 3, 2023 / Medibiofarma, a...